1.Prediction Model for Massive Transfusion in Placenta Previa during Cesarean Section
Jieun KANG ; Hye Sim KIM ; Eun Bi LEE ; Young UH ; Kyoung Hee HAN ; Eun Young PARK ; Hyang Ah LEE ; Dae Ryong KANG ; In Bai CHUNG ; Seong Jin CHOI
Yonsei Medical Journal 2020;61(2):154-160
0.05). The area under the receiver operating characteristics curve (AUC) was 0.922 [95% confidence interval (CI) 0.89–0.95]. In external validation, the discrimination was good, with an AUC value of 0.833 (95% CI 0.70–0.92) for this model. Nomogram calibration plots indicated good agreement between the predicted and observed outcomes, exhibiting close approximation between the predicted and observed probability.CONCLUSION: We constructed a scoring model for predicting massive transfusion during cesarean section in women with placenta previa. This model may help in determining the need to prepare an appropriate amount of blood products and the optimal timing of blood transfusion.]]>
Area Under Curve
;
Blood Transfusion
;
Calibration
;
Cesarean Section
;
Cohort Studies
;
Discrimination (Psychology)
;
Early Intervention (Education)
;
Erythrocytes
;
Female
;
Humans
;
Logistic Models
;
Maternal Age
;
Nomograms
;
Placenta Previa
;
Placenta
;
Placentation
;
Postpartum Hemorrhage
;
Pregnancy
;
ROC Curve
;
Ultrasonography
2.Inhibitory effect of carvacrol on lipopolysaccharide-induced memory impairment in rats
Bombi LEE ; Mijung YEOM ; Insop SHIM ; Hyejung LEE ; Dae hyun HAHM
The Korean Journal of Physiology and Pharmacology 2020;24(1):27-37
Neuroinflammation is an important process underlying a wide variety of neurodegenerative diseases. Carvacrol (CAR) is a phenolic monoterpene commonly used as a food additive due to its antibacterial properties, but it has also been shown to exhibit strong antioxidative, anti-inflammatory, and neuroprotective effects. Here, we sought to investigate the effects of CAR on inflammation in the hippocampus and prefrontal cortex, as well as the molecular mechanisms underlying these effects. In our study, lipopolysaccharide was injected into the lateral ventricle of rats to induce memory impairment and neuroinflammation. Daily administration of CAR (25, 50, and 100 mg/kg) for 21 days improved recognition, discrimination, and memory impairments relative to untreated controls. CAR administration significantly attenuated expression of several inflammatory factors in the brain, including interleukin-1β, tumor necrosis factor-α, and cyclooxygenase-2. In addition, CAR significantly increased expression of brain-derived neurotrophic factor (BDNF) mRNA, and decreased expression of Toll-like receptor 4 (TLR4) mRNA. Taken together, these results show that CAR can improve memory impairment caused by neuroinflammation. This cognitive enhancement is due to the anti-inflammatory effects of CAR medicated by its regulation of BDNF and TLR4. Thus, CAR has significant potential as an inhibitor of memory degeneration in neurodegenerative diseases.
Animals
;
Brain
;
Brain-Derived Neurotrophic Factor
;
Cyclooxygenase 2
;
Cytokines
;
Discrimination (Psychology)
;
Food Additives
;
Hippocampus
;
Inflammation
;
Lateral Ventricles
;
Lipopolysaccharides
;
Memory
;
Necrosis
;
Neurodegenerative Diseases
;
Neuroprotective Agents
;
Phenol
;
Prefrontal Cortex
;
Rats
;
RNA, Messenger
;
Toll-Like Receptor 4
3.Expression and serological application of recombinant epitope-repeat protein carrying an immunodominant epitope of Newcastle disease virus nucleoprotein.
Satish S GAIKWAD ; Hyun Jeong LEE ; Ji Ye KIM ; Kang Seuk CHOI
Clinical and Experimental Vaccine Research 2019;8(1):27-34
PURPOSE: The aim of the present study was to develop a serodiagnostic test for differentiation infected from vaccinated animal (DIVA) strategy accompanying the marker vaccine lacking an immunodominant epitope (IDE) of nucleoprotein of Newcastle disease virus (NDV). MATERIALS AND METHODS: Recombinant epitope-repeat protein (rERP) gene encoding eight repeats of the IDE sequence (ETQFLDLMRAVANSMR) by tetra-glycine linker was synthesized. Recombinant baculovirus carrying the rERP gene was generated to express the rERP in insect cells. Specificity and sensitivity of an indirect enzyme-linked immunosorbent assay (ELISA) employing the rERP was evaluated. RESULTS: The rERP with molecular weight of 20 kDa was successfully expressed by the recombinant baculovirus in an insect-baculovirus system. The rERP was antigenically functional as demonstrated by Western blotting. An indirect ELISA employing the rERP was developed and its specificity and sensitivity was determined. The ELISA test allowed discrimination of NDV infected sera from epitope deletion virus vaccinated sera. CONCLUSION: The preliminary results represent rERP ELISA as a promising DIVA diagnostic tool.
Animals
;
Baculoviridae
;
Blotting, Western
;
Discrimination (Psychology)
;
Enzyme-Linked Immunosorbent Assay
;
Insects
;
Molecular Weight
;
Newcastle disease virus*
;
Newcastle Disease*
;
Nucleoproteins
;
Sensitivity and Specificity
4.Clinical application of the Pediatric Acute Lung Injury Consensus Conference definition of acute respiratory distress syndrome.
Byuh Ree KIM ; Soo Yeon KIM ; In Suk SOL ; Yoon Hee KIM ; Kyung Won KIM ; Myung Hyun SOHN ; Kyu Earn KIM
Allergy, Asthma & Respiratory Disease 2019;7(1):44-50
PURPOSE: Despite improved quality of intensive care, acute respiratory distress syndrome (ARDS) significantly contributes to mortality in critically ill children. As pre-existing definitions of ARDS were adult-oriented standards, the Pediatric Acute Lung Injury Consensus Conference (PALICC) group released a new definition of pediatric ARDS. In this study, we aimed to assess the performance of PALICC definition for ARDS risk stratification. METHODS: Total 332 patients who admitted to the intensive care unit at Severance Hospital from January 2009 to December 2016 and diagnosed as having ARDS by either the PALICC definition or the Berlin definition were retrospectively analyzed. Patient characteristics and mortality rates were compared between the individual severity groups according to both definitions. RESULTS: The overall mortality rate was 36.1%. The mortality rate increased across the severity classes according to both definitions (26% in mild, 37% in moderate and 68% in severe by the PALICC definition [P<0.001]; 20% in mild, 32% in moderate and 64% in severe by the Berlin definition [P<0.001]). The mortality risk increased only for severe ARDS in both definitions (hazard ratio [95% confidence interval]: 2.279 [1.414–3.672], P=0.001 by the PALICC definition; 2.674 [1.518–4.712], P=0.001 by the Berlin definition). There was no significant difference in mortality discrimination between the 2 definitions (difference in integrated area under the curve: 0.017 [−0.018 to 0.049]). CONCLUSION: The PALICC definition demonstrated similar discrimination power on PARDS' severity and mortality as the Berlin definition.
Acute Lung Injury*
;
Berlin
;
Child
;
Consensus*
;
Critical Care
;
Critical Illness
;
Discrimination (Psychology)
;
Humans
;
Intensive Care Units
;
Mortality
;
Respiratory Distress Syndrome, Adult*
;
Retrospective Studies
5.Left Ventricular End-Systolic Volume Can Predict 1-Year Hierarchical Clinical Composite End Point in Patients with Cardiac Resynchronization Therapy.
Jae Sun UHM ; Jaewon OH ; In Jeong CHO ; Minsu PARK ; In Soo KIM ; Moo Nyun JIN ; Han Joon BAE ; Hee Tae YU ; Tae Hoon KIM ; Hui Nam PAK ; Moon Hyoung LEE ; Boyoung JOUNG ; Seok Min KANG
Yonsei Medical Journal 2019;60(1):48-55
PURPOSE: This study aimed to elucidate which echocardiographic criteria at three time points, for cardiac resynchronization therapy (CRT) response, are accurate in discriminating the hierarchical clinical composite end point (HCCEP). MATERIALS AND METHODS: We included 120 patients (age, 66.1±12.6 years; men, 54.2%) who underwent CRT implantation for heart failure (HF). Echocardiography was performed before and at 3, 6, and 12 months after CRT implantation. The 1-year HCCEP included all-cause mortality, hospitalization for HF, and New York Heart Association functional class for 12 months. CRT response criteria were decrease in left ventricular (LV) end-systolic volume (LVESV) >15%, decrease in LV end-diastolic volume >15%, absolute increase in LV ejection fraction (LVEF) ≥5%, relative increase in LVEF ≥15%, and decrease in mitral regurgitation ≥1 grade. Temporal changes in CRT response rates, accuracy of CRT response criteria at each time and cutoff value for the discrimination of improvement in HCCEP, and agreements with improvement in HCCEP were analyzed. RESULTS: HCCEP improvement rates were 65.8% in total group. In nonischemic group, CRT response rates according to all echocardiographic criteria significantly increased with time. In ischemic group, CRT response rate did not significantly change with time. In total group, ΔLVESV at 6 months (ΔLVESV6) had the most significant accuracy for the discrimination of HCCEP (area under the curve=0.781). The optimal cutoff value of ΔLVESV6 was 13.5% (sensitivity=0.719, specificity=0.719). ΔLVESV6 had fair agreement with HCCEP (κ=0.391, p < 0.001). CONCLUSION: ΔLVESV6 is the most useful echocardiographic CRT response criterion for the prediction of 1-year HCCEP.
Cardiac Resynchronization Therapy*
;
Discrimination (Psychology)
;
Echocardiography
;
Heart
;
Heart Failure
;
Hospitalization
;
Humans
;
Male
;
Mitral Valve Insufficiency
;
Mortality
;
Stroke Volume*
6.Clinical significance of cell-free DNA as a prognostic biomarker in patients with diffuse large B-cell lymphoma
Mahsa ESKANDARI ; Saba MANOOCHEHRABADI ; Hossein PASHAIEFAR ; Mohammad Ali ZAIMY ; Mohammad AHMADVAND
Blood Research 2019;54(2):114-119
BACKGROUND: Cell-free DNA (cfDNA) has the potential to serve as a non-invasive prognostic biomarker in some types of neoplasia. The investigation of plasma concentration of cfDNA may reveal its use as a valuable biomarker for risk stratification of diffuse large B-cell lymphoma (DLBCL). The present prognostic value of plasma cfDNA has not been widely confirmed in DLBCL subjects. Here, we evaluated cfDNA plasma concentration and assessed its potential prognostic value as an early DLBCL diagnostic tool. METHODS: cfDNA concentrations in plasma samples from 40 patients with DLBCL during diagnosis and of 38 normal controls were determined with quantitative polymerase chain reaction (qPCR) for the multi-locus L1PA2 gene. RESULTS: Statistically significant elevation in plasma cfDNA concentrations was observed in patients with DLBCL as compared to that in normal controls (P<0.05). A cutoff point of 2.071 ng/mL provided 82.5% sensitivity and 62.8% specificity and allowed successful discrimination of patients with DLBCL from normal controls (area under the curve=0.777; P=0.00003). Furthermore, patients with DLBCL showing higher concentrations of cfDNA had shorter overall survival (median, 9 mo; P=0.022) than those with lower cfDNA levels. In addition, elevated cfDNA concentration was significantly associated with age, B-symptoms, International Prognostic Index (IPI) score, and different stages of disease (all P<0.05). CONCLUSION: Quantification of cfDNA with qPCR at the time of diagnosis may allow identification of patients with high cfDNA concentration, which correlates with aggressive clinical outcomes and adverse prognosis.
B-Lymphocytes
;
Diagnosis
;
Discrimination (Psychology)
;
DNA
;
Humans
;
Lymphoma, B-Cell
;
Plasma
;
Polymerase Chain Reaction
;
Prognosis
;
Sensitivity and Specificity
7.Validation of the 8th AJCC Cancer Staging System for Pancreas Neuroendocrine Tumors Using Korean Nationwide Surgery Database
Yunghun YOU ; Jin Young JANG ; Song Cheol KIM ; Yoo Seok YOON ; Joon Seong PARK ; Chol Kyoon CHO ; Sang Jae PARK ; Jae Do YANG ; Woo Jung LEE ; Tae Ho HONG ; Keun Soo AHN ; Chi Young JEONG ; Hyeon Kook LEE ; Seung Eun LEE ; Young Hoon ROH ; Hee Joon KIM ; Hongbeom KIM ; In Woong HAN
Cancer Research and Treatment 2019;51(4):1639-1652
PURPOSE: The 8th edition of the American Joint Committee on Cancer (AJCC) staging system for pancreatic neuroendocrine tumor (PNET) included several significant changes. We aim to evaluate this staging system compared to the 7th edition AJCC staging system and European Neuroendocrine Tumors Society (ENETS) system. MATERIALS AND METHODS: We used Korean nationwide surgery database (2000-2014). Of 972 patients who had undergone surgery for PNET, excluding patients diagnosed with ENETS/World Health Organization 2010 grade 3 (G3), only 472 patients with accurate stage were included. RESULTS: Poor discrimination in overall survival rate (OSR) was noted between AJCC 8th stage III and IV (p=0.180). The disease-free survival (DFS) curves of 8th AJCC classification were well separated between all stages. Compared with stage I, the hazard ratio of II, III, and IV was 3.808, 13.928, and 30.618, respectively (p=0.007, p < 0.001, and p < 0.001). The curves of OSR and DFS of certain prognostic group in AJCC 7th and ENETS overlapped. In ENETS staging system, no significant difference in DFS between stage IIB versus IIIA (p=0.909) and IIIA versus IIIB (p=0.291). In multivariable analysis, lymphovascular invasion (p=0.002), perineural invasion (p=0.003), and grade (p < 0.001) were identified as independent prognostic factors for DFS. CONCLUSION: This is the first large-scale validation of the AJCC 8th edition staging system for PNET. The revised 8th system provides better discrimination compared to that of the 7th edition and ENETS TNM system. This supports the clinical use of the system.
Classification
;
Discrimination (Psychology)
;
Disease-Free Survival
;
Humans
;
Joints
;
Neoplasm Staging
;
Neuroectodermal Tumors, Primitive
;
Neuroendocrine Tumors
;
Pancreas
;
Survival Rate
8.Novel Prognostic Nomograms Based on Inflammation-Related Markers for Patients with Hepatocellular Carcinoma Underwent Hepatectomy
Yifei WANG ; Kaiyu SUN ; Jingxian SHEN ; Bin LI ; Ming KUANG ; Qinghua CAO ; Sui PENG
Cancer Research and Treatment 2019;51(4):1464-1478
PURPOSE: Hepatocellular carcinoma (HCC) is an aggressive disease with high recurrence rate. However, current staging systems were lack of predictive capacity for HCC recurrence. We aimed to develop prognostic nomograms based on inflammation-related markers for HCC patients underwent hepatectomy. MATERIALS AND METHODS: We recruited 889 surgically treated patients from two medical centers. Independent prognostic factors were identified by cox regression analyses. Nomograms for recurrence-free survival (RFS) and overall survival (OS) were established, and validated internally and externally. The performance, discrimination, and calibration of nomograms were assessed, and compared with existed staging systems. RESULTS: Neutrophil to lymphocyte ratio (NLR) and gamma-glutamyl transpeptidase to platelet ratio (GPR) were the two inflammation-related factor that independently correlated with survival. NLR, GPR, international normalized ratio (INR), microvascular invasion, satellite lesions, tumour number, tumour diameter, and macrovascular invasion were used to construct nomogram for RFS while GPR, total bilirubin, INR, α-fetoprotein, microvascular invasion, satellite lesions, tumour diameter, and macrovascular invasion were for OS. In the training cohort, the C-index of nomogram was 0.701 (95% confidence interval [CI], 0.669 to 0.732) for RFS and 0.761 (95% CI, 0.728 to 0.795) for OS. These results received both internal and external validation with C-index of 0.701 (95% CI, 0.647 to 0.755) and 0.707 (95% CI, 0.657 to 0.756) for RFS, and 0.706 (95% CI, 0.640 to 0.772) and 0.708 (95% CI, 0.646 to 0.771) for OS, respectively. The nomograms showed superior accuracy to conventional staging systems (p<0.001). CONCLUSION: The nomograms based on inflammation-related markers are of high efficacy in predicting survival of HCC patients after hepatectomy, which will be valuable in guiding postoperative interventions and follow-ups.
Bilirubin
;
Blood Platelets
;
Calibration
;
Carcinoma, Hepatocellular
;
Cohort Studies
;
Discrimination (Psychology)
;
Follow-Up Studies
;
gamma-Glutamyltransferase
;
Hepatectomy
;
Humans
;
Inflammation
;
International Normalized Ratio
;
Lymphocytes
;
Neutrophils
;
Nomograms
;
Recurrence
9.Nomogram Development and External Validation for Predicting the Risk of Lymph Node Metastasis in T1 Colorectal Cancer
Jung Ryul OH ; Boram PARK ; Seongdae LEE ; Kyung Su HAN ; Eui Gon YOUK ; Doo Han LEE ; Do Sun KIM ; Doo Seok LEE ; Chang Won HONG ; Byung Chang KIM ; Bun KIM ; Min Jung KIM ; Sung Chan PARK ; Dae Kyung SOHN ; Hee Jin CHANG ; Jae Hwan OH
Cancer Research and Treatment 2019;51(4):1275-1284
PURPOSE: Predicting lymph node metastasis (LNM) risk is crucial in determining further treatment strategies following endoscopic resection of T1 colorectal cancer (CRC). This study aimed to establish a new prediction model for the risk of LNM in T1 CRC patients. MATERIALS AND METHODS: The development set included 833 patients with T1 CRC who had undergone endoscopic (n=154) or surgical (n=679) resection at the National Cancer Center. The validation set included 722 T1 CRC patients who had undergone endoscopic (n=249) or surgical (n=473) resection at Daehang Hospital. A logistic regression model was used to construct the prediction model. To assess the performance of prediction model, discrimination was evaluated using the receiver operating characteristic (ROC) curves with area under the ROC curve (AUC), and calibration was assessed using the Hosmer-Lemeshow (HL) goodness-of-fit test. RESULTS: Five independent risk factors were determined in the multivariable model, including vascular invasion, high-grade histology, submucosal invasion, budding, and background adenoma. In final prediction model, the performance of the model was good that the AUC was 0.812 (95% confidence interval [CI], 0.770 to 0.855) and the HL chi-squared test statistic was 1.266 (p=0.737). In external validation, the performance was still good that the AUC was 0.771 (95% CI, 0.708 to 0.834) and the p-value of the HL chi-squared test was 0.040. We constructed the nomogram with the final prediction model. CONCLUSION: We presented an externally validated new prediction model for LNM risk in T1 CRC patients, guiding decision making in determining whether additional surgery is required after endoscopic resection of T1 CRC.
Adenoma
;
Area Under Curve
;
Calibration
;
Colorectal Neoplasms
;
Decision Making
;
Discrimination (Psychology)
;
Humans
;
Logistic Models
;
Lymph Nodes
;
Neoplasm Metastasis
;
Nomograms
;
Risk Factors
;
ROC Curve
10.Schizophrenia and Corollary Discharge: A Neuroscientific Overview and Translational Implications
Rujuta PARLIKAR ; Anushree BOSE ; Ganesan VENKATASUBRAMANIAN
Clinical Psychopharmacology and Neuroscience 2019;17(2):170-182
Corollary discharge mechanism refers to the suppression of sensory consequences of self-generated actions; a process that serves to distinguish between self and non-self based on discrimination of origination of action. It explains, say for example, why we cannot tickle ourselves. This review discusses how corollary discharge model is an essential neural integration mechanism central to the motor functioning of animal kingdom. In this article, research conducted in the field of corollary discharge has been reviewed to understand the neuroanatomical and neurophysiological basis of corollary discharge and gain insight into the biochemical basis of its dysfunction. This review article also explores the role of corollary discharge and its dysfunction in the presentation of symptoms of schizophrenia, discussing the findings from corollary discharge studies on schizophrenia population. Lastly, the link between schizophrenia psychopathology and corollary discharge dysfunction has been highlighted, and an attempt has been made to establish a case for correction of corollary discharge deficit in schizophrenia through neuromodulation.
Animals
;
Discrimination (Psychology)
;
Hallucinations
;
Motor Activity
;
Psychopathology
;
Schizophrenia
;
Transcranial Direct Current Stimulation

Result Analysis
Print
Save
E-mail